… disease severity scores for autoimmune blistering diseases. … led to its US Food and Drug
Administration (FDA) indication for … in subepidermal autoimmune blistering diseases (s-AIBDs). …

… on QoL, complications of disease and therapy. Autoimmune Blistering Diseases occurring in
… A consensus on diagnostic criteria will be useful for clinical trials and ascertaining the most …

… subepidermal blistering diseases have autoantibodies … research over the past 25 years
has demonstrated that patients with pemphigus, BP, and other autoimmune blistering diseases …

… Bullous pemphigoid (BP) is a severe autoimmune blistering skin disorder that primarily causes
disease … most prevalent subepidermal variant of the pemphigoid diseases. It manifests as …

… autoimmune blistering disease in children. It can clinically resemble BP (anti-laminin-γ1
pemphigoid, also known as anti-p200 pemphigoid, can do this as well); in linear IgA dermatosis, …

… We queried the clinical trial registries of ClinicalTrials.gov and … ” OR “pemphigoid” OR “autoimmune
bullous disease”) and … autoimmune bullous diseases to the best of our knowledge. …

… Autoimmune blistering diseases comprise a group of heterogenous conditions … A
phase 2 clinical trial of VAY736 in patients with PV is currently underway.(NCT01930175). …

… therapies are in various stages of development, with existing TNF-α inhibitors showing
efficacy in treating AIBDs and antibodies against IL-5 and eotaxin-1 having entered clinical trials …

… Clinical classification Autoimmune bullous diseases have a broad spectrum of clinical
manifestations and a variety of morphological lesions. Based on the level of the skin …

… Since our understanding of autoimmune bullous diseases … of which have changed the
prognosis of these diseases [11-14]. … Clinical studies are hampered by the relatively low incidence …